Position in LUNG
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$787
+$389 QoQ
Shares Held
606
+96.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 107 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LUNG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Farther Finance Advisors, LLC holds $24,036,684 across 91 Medical Devices names. LUNG ranks #65 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
73,946 | $6,709,860 | |
| 2 | SYK |
Stryker Corp
|
17,426 | $5,486,401 | |
| 3 | MDT |
Medtronic plc
|
65,993 | $5,162,632 | |
| 4 | BSX |
Boston Scientific Corp
|
28,699 | $1,224,873 | |
| 5 | EW |
Edwards Lifesciences Corp
|
12,482 | $1,129,121 | |
| 6 | DXCM |
Dexcom Inc
|
9,967 | $671,277 | |
| 7 | STE |
STERIS plc
|
2,980 | $627,498 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
8,545 | $546,965 |
All Filings in LUNG
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $787 | 606 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $398 | 309 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $209 | 95 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $153 | 95 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2 | 1 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $13 | 2 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $13 | 2 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $16 | 2 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $12 | 2 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $37 | 4 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $573 | 45 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||